With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage ...

Long Covid remains poorly understood and follow-up studies play an integral role in establishing an epidemiological and ...

Hoth Therapeutics has reported interim data from a trial of HT-001, a drug designed for treating pruritus associated with ...

Genesis has gained US Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) application for a ...

Accent Therapeutics has dosed the first subject in an open-label Phase I/II trial of ATX-295, an oral kinesin family member ...

More than just a tool for advancing pipelines, trial efficiency is the name of the game when it comes to synthetic control ...